Full Text View
Tabular View
No Study Results Posted
Related Studies
Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization (DECIPHER)
This study is ongoing, but not recruiting participants.
Study NCT00074724   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: December 19, 2003   Last Updated: May 14, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Diseases
Coronary Disease
Heart Failure
Heart Failure, Congestive
Heart Diseases
Additional conditions recognized in this trial
Coronary Artery Disease
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Myocardial Ischemia
Vascular Diseases
Interventions listed in this trial
Coronary Artery Bypass
Modern medical management
Dobutamine echocardiography
Optimal medical therapy
Additional drug interventions recognized in this trial
Dobutamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-Agonists
Autonomic Agents
Cardiotonic Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services